Maravai LifeSciences Stock (NASDAQ: MRVI)

Maravai LifeSciences

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Munich,,Bavaria,,Germany,-,March,31,2023:,Maravai,Lifesciences,Provides

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

MRVI

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

Gamestop, Lululemon, Uber, Ulta Beauty And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Intraday Update

Movers

AUNA

DGICB

FUFU

MBLY

POET

SKYH

TITN

Trump Media &amp; Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday

Crude Oil 6- logo

Equities

Eurozone

Commodities

IGMS

VMAR

Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences Holdings Inc

Legal

Press Releases

MRVI DEADLINE TODAY: Maravai LifeSciences (MRVI) Investors Alerted to Today's Lead Plaintiff Deadline in Securities Class Action

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI

Penny Stocks

Small Cap

MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact Levi & Korsinsky about pending Class Action - MRVI

Maravai Lifesciences Reports First Quarter 2025 Financial Results

TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

Maravai LifeSciencesReleases 2024 Sustainability Report

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Codexis

Cytek Biosciences

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Maravai LifeSciences

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell